From Gizmodo: ‘Major Biomedical Triumph’ as Scientists Restore Seven-Year-Old Boy’s Skin

Junctional epidermolysis bullosa is the sort of rare disease you are probably lucky to have never heard of. An often lethal genetic condition, from infancy it plagues its victim with painful blisters all over the body that causes the skin to become ext…

Read more

From Geek.com: FDA approves Revolutionary Cancer Drug

The Food and Drug Administration — the American agency in charge of ensuring the safety of most of the things we ingest — has approved a radical new therapy for fighting cancer called […]
The post FDA approves Revolutionary Cancer Dru…

Read more

From Gizmodo: The FDA Just Approved Another Promising Immunotherapy For Cancer

On Wednesday—for only the second time—the Food and Drug Administration approved a cutting-edge therapy that genetically modifies a patient’s blood cells in order to attack cancer. This time the therapy, known as CAR T-cell therapy, is designed to…

Read more

From Gizmodo: An FDA Panel Just Greenlit a Breakthrough Gene Therapy to Cure Blindness

On Thursday, a US Food and Drug Administration review panel gave their stamp of approval to an experimental gene therapy for a rare inherited form of blindness. If ultimately approved by the agency, the technique would be the first gene therapy for an …

Read more

From Gizmodo: The FDA is Considering a Landmark Approval of Gene Therapy to Cure Blindness

On Tuesday, a US Food and Drug Administration review committee published a document signaling that a historic moment in medicine may be on the horizon. The committee found that an experimental gene therapy for a rare inherited form of blindness improve…

Read more

From ExtremeTechExtremeTech: What is Cord Blood Banking?

Cord blood banking is a relatively new concept. We discuss the technology, its implementation, whether it’s worth considering for a newborn child, and how people are opting to store this blood for years — or decades.
The post What is Cord Blood Bankin…

Read more

From Gizmodo: The FDA Just Approved the First ‘Living’ Therapy to Treat Childhood Leukemia

On Wednesday, the Food and Drug Administration approved a treatment that genetically modifies a patient’s own blood cells in order to attack childhood leukemia, a landmark decision opens the door for an era of FDA-sanctioned human gene modification.

Read more…

Read more